• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy, by The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N. Engl. J. Med 342:381-9, 2000.

作者信息

Barr C C

出版信息

Surv Ophthalmol. 2001 Mar-Apr;45(5):459-60. doi: 10.1016/s0039-6257(01)00187-4.

DOI:10.1016/s0039-6257(01)00187-4
PMID:11274700
Abstract
摘要

相似文献

1
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy, by The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N. Engl. J. Med 342:381-9, 2000.强化胰岛素治疗试验四年后1型糖尿病患者的视网膜病变和肾病，由糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究组完成。《新英格兰医学杂志》342:381 - 389，2000年。
Surv Ophthalmol. 2001 Mar-Apr;45(5):459-60. doi: 10.1016/s0039-6257(01)00187-4.
2
From the control tower: some is better than none and a little bit goes a long way.从指挥塔传来消息：有总比没有好，一点点也能发挥很大作用。
J Pediatr. 2001 Dec;139(6):766-8. doi: 10.1067/mpd.2001.120053.
3
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).青少年期强化糖尿病治疗的有益效果：糖尿病控制与并发症试验（DCCT）结束后的结果
J Pediatr. 2001 Dec;139(6):804-12. doi: 10.1067/mpd.2001.118887.
4
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.强化治疗对1型糖尿病患者视网膜病变并发症风险的长期影响：糖尿病控制与并发症试验10年后
Arch Ophthalmol. 2008 Dec;126(12):1707-15. doi: 10.1001/archopht.126.12.1707.
5
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.强化治疗试验四年后1型糖尿病患者的视网膜病变和肾病
N Engl J Med. 2000 Feb 10;342(6):381-9. doi: 10.1056/NEJM200002103420603.
6
The effect of pregnancy on the natural history of diabetic retinopathy and nephropathy.妊娠对糖尿病视网膜病变和肾病自然病程的影响。
Clin Perinatol. 1998 Dec;25(4):887-916.
7
Diabetes in childhood: predicting the future.儿童期糖尿病：预测未来
Pediatr Ann. 1994 Jun;23(6):306-12. doi: 10.3928/0090-4481-19940601-10.
8
Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.肾素-血管紧张素系统（RAS）阻断与眼部和肾脏的糖尿病微血管并发症
Prim Care Diabetes. 2008 Dec;2(4):201-2. doi: 10.1016/j.pcd.2008.06.002. Epub 2008 Aug 28.
9
Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.在糖尿病控制与并发症试验以及糖尿病干预与并发症流行病学研究中，1型糖尿病患者皮肤胶原蛋白中的糖基化和羧甲基赖氨酸水平可预测未来10年糖尿病视网膜病变和肾病进展的风险。
Diabetes. 2005 Nov;54(11):3103-11. doi: 10.2337/diabetes.54.11.3103.
10
[Clinical study of the month. After DCCT, the EDIC study].[本月临床研究。糖尿病控制与并发症试验（DCCT）之后的糖尿病干预和并发症流行病学研究（EDIC）]
Rev Med Liege. 2000 Mar;55(3):187-9.

引用本文的文献

1
Multi-omics analysis of potential metabolic networks linking peripheral metabolic changes to inflammatory retinal conditions in STZ-induced early diabetic retinopathy.链脲佐菌素诱导的早期糖尿病视网膜病变中，将外周代谢变化与炎症性视网膜疾病相联系的潜在代谢网络的多组学分析。
Biochem Biophys Rep. 2025 Aug 22;43:102182. doi: 10.1016/j.bbrep.2025.102182. eCollection 2025 Sep.
2
Factors Affecting Intensive Aflibercept Treatment Response in Diabetic Macular Edema: A Real-World Study.影响糖尿病性黄斑水肿密集型阿柏西普治疗反应的因素：一项真实世界研究。
J Diabetes Res. 2023 Jul 18;2023:1485059. doi: 10.1155/2023/1485059. eCollection 2023.
3
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
增生性糖尿病性视网膜病变在糖尿病性视网膜病变患者中发展和进展的预测因素。
Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2.
4
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.美国临床内分泌学会临床实践指南：制定糖尿病综合护理计划-2022 更新版。
Endocr Pract. 2022 Oct;28(10):923-1049. doi: 10.1016/j.eprac.2022.08.002. Epub 2022 Aug 11.
5
Nucleoporin 160 (NUP160) inhibition alleviates diabetic nephropathy by activating autophagy.核孔蛋白 160（NUP160）抑制通过激活自噬减轻糖尿病肾病。
Bioengineered. 2021 Dec;12(1):6390-6402. doi: 10.1080/21655979.2021.1968777.
6
Design of dual hormone blood glucose therapy and comparison with single hormone using MPC algorithm.基于 MPC 算法的双激素血糖治疗设计及与单激素治疗的比较。
IET Syst Biol. 2020 Oct;14(5):241-251. doi: 10.1049/iet-syb.2020.0053.
7
Emerging Concepts in the Treatment of Diabetic Retinopathy.糖尿病视网膜病变治疗新观念。
Curr Diab Rep. 2019 Nov 20;19(11):137. doi: 10.1007/s11892-019-1276-5.
8
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach.糖尿病视网膜病变中视网膜和循环 miRNA 的表达模式：一种计算机模拟和体内研究方法。
Br J Pharmacol. 2019 Jul;176(13):2179-2194. doi: 10.1111/bph.14665. Epub 2019 May 9.
9
Ferulic Acid Protects Hyperglycemia-Induced Kidney Damage by Regulating Oxidative Insult, Inflammation and Autophagy.阿魏酸通过调节氧化损伤、炎症和自噬来保护高血糖诱导的肾脏损伤。
Front Pharmacol. 2019 Feb 5;10:27. doi: 10.3389/fphar.2019.00027. eCollection 2019.
10
Association of homocysteine with type 1 diabetes mellitus: a meta-analysis.同型半胱氨酸与1型糖尿病的关联：一项荟萃分析。
Int J Clin Exp Med. 2015 Aug 15;8(8):12529-38. eCollection 2015.